Blood test breakthrough could spot kidney cancer sooner
NCT ID NCT06917560
First seen Oct 31, 2025 · Last updated May 16, 2026 · Updated 27 times
Summary
This study looks at whether specific antibodies in the blood can help detect kidney cancer earlier and predict how the disease will progress. Researchers will analyze data from 400 patients to build a model that guides personalized treatment and avoids unnecessary risks. The goal is to improve quality of life and outcomes for people with kidney cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
first hospital affiliated of Fujian medical university
Fuzhou, Fujian, 350005, China
Conditions
Explore the condition pages connected to this study.